EMEND caps 1x125mg, 2x80mg 3 pce

7680563590021 CH-56359 A04AD12 01.09.0.

Reimbursement limitations:

EMEND125_80

Traitement des vomissements dus à une chimiothérapie avec effet hautement émétisant, durant trois jours maximum.

EMEND caps 1x125mg, 2x80mg 3 pce
EMEND caps 1x125mg, 2x80mg 3 pce
1 / 2
google

Details

Product number
5635902
CPT
-
Packaging group
3
Unit
Kapsel(n)
Composition
aprepitantum 125 mg, excipiens pro capsula.

Articles (1)

Emend 125 mg, Kapseln
Kapseln
3
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
18/09/2025
Patient information leaflet
Français
18/09/2025
Patient information leaflet
Italien
18/09/2025
Professional SmPC
Allemand
18/09/2025
Professional SmPC
Français
18/09/2025
Professional SmPC
Italien
18/09/2025

Detailed composition

Substance Quantity Type Category
(N/A)
125.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
125.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
0.1728 MG Substance HBESI

Reimbursement information

Public price
CHF 76.80
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/2004

Authorization holder

MSD Merck Sharp & Dohme AG

6005 Luzern

Authorization information

Swissmedic authorization number
56359
Drug name
Emend, Hartkapseln
Galenic form
KAHA
ATC Code
A04AD12
Authorization status
Z
Dispensation category
B
First authorization
02/12/2003
Authorization expiration date
31/12/9999
IT number
01.09.0.
Domain
Human medicine
Field of application
Antiemetikum

Packaging details

Description (FR)
EMEND 125 mg caps 3 pce
Description (DE)
EMEND 125 mg Kaps 3 Stk
Market launch
02/12/2003
Narcotic (BTM)
No

Other packaging sizes